ALTO INGREDIENTS INC(NASDAQ:ALTO) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALTO. ALTO was compared to 85 industry peers in the Chemicals industry. Both the profitability and financial health of ALTO have multiple concerns. ALTO is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALTO has reported negative net income.

In the past year ALTO has reported a negative cash flow from operations.

In the past 5 years ALTO reported 4 times negative net income.

Of the past 5 years ALTO 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of ALTO (-15.01%) is worse than 82.35% of its industry peers.

With a Return On Equity value of -26.77%, ALTO is not doing good in the industry: 78.82% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-15.01%
ROE	-26.77%
ROIC	N/A

ROA(3y)-10.14%

ROA(5y)-4.95%

ROE(3y)-17.06%

ROE(5y)-8.78%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 1.01%, ALTO is doing worse than 88.24% of the companies in the same industry.

In the last couple of years the Gross Margin of ALTO has declined.

ALTO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.01%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-43.6%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALTO has been increased compared to 1 year ago.

ALTO has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ALTO has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.12, we must say that ALTO is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.12, ALTO is doing worse than 80.00% of the companies in the same industry.

A Debt/Equity ratio of 0.41 indicates that ALTO is not too dependend on debt financing.

The Debt to Equity ratio of ALTO (0.41) is better than 68.24% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.41
Debt/FCF	N/A
Altman-Z	-0.12

ROIC/WACCN/A

WACC9.96%

2.3 Liquidity

ALTO has a Current Ratio of 2.65. This indicates that ALTO is financially healthy and has no problem in meeting its short term obligations.

ALTO has a Current ratio of 2.65. This is in the better half of the industry: ALTO outperforms 78.82% of its industry peers.

A Quick Ratio of 1.79 indicates that ALTO should not have too much problems paying its short term obligations.

With a decent Quick ratio value of 1.79, ALTO is doing good in the industry, outperforming 76.47% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.65
Quick Ratio	1.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -112.82%.

ALTO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.07%.

ALTO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.49% yearly.

EPS 1Y (TTM)-112.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-119.23%

Revenue 1Y (TTM)-21.07%

Revenue growth 3Y-7.2%

Revenue growth 5Y-7.49%

Sales Q2Q%-13.62%

3.2 Future

The Earnings Per Share is expected to grow by 34.90% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 12.23% on average over the next years. This is quite good.

EPS Next Y63.13%

EPS Next 2Y47.8%

EPS Next 3Y34.9%

EPS Next 5YN/A

Revenue Next Year-0.57%

Revenue Next 2Y2.61%

Revenue Next 3Y12.23%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTO. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALTO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

77.65% of the companies in the same industry are cheaper than ALTO, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	28.59

4.3 Compensation for Growth

ALTO's earnings are expected to grow with 34.90% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y47.8%

EPS Next 3Y34.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALTO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALTO INGREDIENTS INC

NASDAQ:ALTO (4/25/2025, 8:00:00 PM)

After market: 0.9477 +0.05 (+5.12%)

0.9015

+0.01 (+1.29%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)03-05 2025-03-05/amc

Earnings (Next)05-12 2025-05-12/amc

Inst Owners36.77%

Inst Owner Change-0.62%

Ins Owners4.89%

Ins Owner Change6.74%

Market Cap69.06M

Analysts82.5

Price Target4.59 (409.15%)

Short Float %1.61%

Short Ratio1.72

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.02

Dividend Growth(5Y)-2.34%

DP-2.11%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-298.99%

Min EPS beat(2)-385.93%

Max EPS beat(2)-212.04%

EPS beat(4)1

Avg EPS beat(4)-140.49%

Min EPS beat(4)-385.93%

Max EPS beat(4)50.98%

EPS beat(8)2

Avg EPS beat(8)-89.89%

EPS beat(12)3

Avg EPS beat(12)-1076.75%

EPS beat(16)5

Avg EPS beat(16)-679.37%

Revenue beat(2)1

Avg Revenue beat(2)-1.82%

Min Revenue beat(2)-7.73%

Max Revenue beat(2)4.09%

Revenue beat(4)2

Avg Revenue beat(4)1.16%

Min Revenue beat(4)-7.73%

Max Revenue beat(4)8.57%

Revenue beat(8)5

Avg Revenue beat(8)0.63%

Revenue beat(12)7

Avg Revenue beat(12)0.34%

Revenue beat(16)10

Avg Revenue beat(16)1.23%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-900%

EPS NY rev (1m)-246.34%

EPS NY rev (3m)-246.34%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-5.89%

Revenue NY rev (1m)-7.39%

Revenue NY rev (3m)-7.39%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.07
P/FCF	N/A
P/OCF	N/A
P/B	0.31
P/tB	0.31
EV/EBITDA	28.59

EPS(TTM)-0.83

EYN/A

EPS(NY)-0.31

Fwd EYN/A

FCF(TTM)-0.19

FCFYN/A

OCF(TTM)-0.05

OCFYN/A

SpS12.6

BVpS2.94

TBVpS2.88

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.01%
ROE	-26.77%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.01%
FCFM	N/A

ROA(3y)-10.14%

ROA(5y)-4.95%

ROE(3y)-17.06%

ROE(5y)-8.78%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-43.6%

GM growth 5YN/A

F-Score2

Asset Turnover2.4

Health

		Industry Rank	Sector Rank
Debt/Equity	0.41
Debt/FCF	N/A
Debt/EBITDA	21.14
Cap/Depr	45.34%
Cap/Sales	1.15%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.65
Quick Ratio	1.79
Altman-Z	-0.12

F-Score2

WACC9.96%

ROIC/WACCN/A

Cap/Depr(3y)107.88%

Cap/Depr(5y)83.14%

Cap/Sales(3y)2.13%

Cap/Sales(5y)1.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-112.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-119.23%

EPS Next Y63.13%

EPS Next 2Y47.8%

EPS Next 3Y34.9%

EPS Next 5YN/A

Revenue 1Y (TTM)-21.07%

Revenue growth 3Y-7.2%

Revenue growth 5Y-7.49%

Sales Q2Q%-13.62%

Revenue Next Year-0.57%

Revenue Next 2Y2.61%

Revenue Next 3Y12.23%

Revenue Next 5YN/A

EBIT growth 1Y-18.37%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year167.99%

EBIT Next 3Y64.22%

EBIT Next 5YN/A

FCF growth 1Y-94.34%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-115.99%

OCF growth 3YN/A

OCF growth 5YN/A

ALTO INGREDIENTS INC (ALTO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens